PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)

被引：0

作者：

Shih, Kent ^{[1
,5
]}

Patel, Manish ^{[2
,5
]}

Butowski, Nicholas ^{[3
]}

Bacha, Jeffrey ^{[4
]}

Brown, Dennis ^{[4
]}

Garner, William ^{[4
]}

Steino, Anne ^{[4
]}

Schwartz, Richard ^{[4
]}

Kanekal, Sarath ^{[4
]}

Lopez, Lorena ^{[4
]}

Burris, Howard A., III ^{[1
,5
]}

机构：

[1] Tenessee Oncol, Nashville, TN USA

[2] Florida Canc Specialists & Res Inst, Gainesville, FL USA

[3] Univ Calif San Francisco, Div NeuroOncol, San Francisco, CA 94143 USA

[4] DelMar Pharmaceut Inc, Vancouver, BC, Canada

[5] Sarah Cannon Res Inst, Nashville, TN USA

来源：

NEURO-ONCOLOGY | 2014年 / 16卷

关键词：

D O I：

10.1093/neuonc/nou237.52

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AT-53

引用

页数：1

共 50 条

[1] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
Shih, Kent C.
Patel, Manish R.
Butowski, Nicholas A.
Bacha, Jeffrey A.
Brown, Dennis
Garner, William J.
Stelno, Anne
Schwartz, Richard Stephen
Kanekal, Sarath
Lopez, Lorena
Burris, Howard A.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[2] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme
Shih, Kent C.
Patel, Manish R.
Butowski, Nicholas
Bacha, Jeffrey A.
Brown, Dennis M.
Steino, Anne
Schwartz, Richard
Kanekai, Sarath
Lopez, Lorena M.
Burris, Howard A.
CANCER RESEARCH, 2015, 75
[3] Phase I study of gefitinib and rapamycin in adult patients with recurrent glioblastoma multiforme (GBM).
Phuphanich, Surasak
Chu, Ray
Yu, John S.
Black, Keith L.
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3462S - 3462S
[4] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioma.
Shih, Kent C.
Patel, Manish R.
Butowski, Nicholas A.
Bacha, Jeffrey A.
Brown, Dennis
Steino, Anne
Schwartz, Richard Stephen
Kanekal, Sarath
Lopez, Lorena
Jones, Suzanne Fields
Burris, Howard A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)
Reardon, David
Groves, Morris
Wen, Patrick
Nabors, Louis
Mikkelsen, Tom
Rosenfeld, Steve
Harris, Dean
DeMarini, Douglas
Suttle, Ben
Arumugham, Thangam
Hodge, Jeffrey
Lager, Joanne
NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
[6] Phase II trial of bevacizumab and erlotinib in recurrent glioblastoma multiforme (GBM)
Sathornsumetee, Sith
Vredenburgh, James
Rich, Jeremy
Desjardins, Annick
Quinn, Jennifer
Bota, Daniela
Goli, Krishna
Mathe, Alyssa
Gururangan, Sridharan
Friedman, Allan
Friedman, Henry
Reardon, David
NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
[7] Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme
Shih, Kent C.
Patel, Manish R.
Bacha, Jeffrey
Brown, Dennis M.
Garner, William J.
Steino, Anne
Schwartz, Richard S.
Kanekal, Sarath
Li, Mike
Lopez, Lorena M.
Burris, Howard A.
CANCER RESEARCH, 2014, 74 (19)
[8] Phase I trial of imatinib mesylate, hydroxyurea and vatalanib for patients with recurrent glioblastoma multiforme (GBM)
Sathornsumetee, S.
Rich, J. N.
Vredenburgh, J. J.
Desjardins, A.
Quinn, J. A.
Gururangan, S.
Egorin, M. J.
Salvado, A. J.
Friedman, H. S.
Reardon, D. A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[9] Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM)
Friedman, H. S.
Desjardins, A.
Vredenburgh, J. J.
Rich, J. N.
Sathornsumetee, S.
Gururangan, S.
Quinn, J. A.
Reardon, D. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[10] A phase I trial of gefitinib and sirolimus in adults with recurrent glioblastoma multiforme (GBM)
Phuphanich, S.
Rudnick, J.
Chu, R.
Yu, J. S.
Black, K. L.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →